Mexiletine

CHEMBL558 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
179.3 g/mol
LogP
2.1
Phase
4

This medication works similarly to lidocaine to stabilize the electrical activity of the heart and nerve fibers, reducing abnormal rhythms and pain signals. It is used to treat certain heart arrhythmias and some forms of chronic nerve pain.

Masse moléculaire

179,2600 g/mol

LogP

2,10

TPSA

35,30 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cccc(C)c1OCC(C)N

InChI

InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3

Molecular Formula

C11H17NO

HBD / HBA

1 / 2

Liaisons Rotatives

3

Atomes Lourds

13

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This medication works similarly to lidocaine to stabilize the electrical activity of the heart and nerve fibers, reducing abnormal rhythms and pain signals. It is used to treat certain heart arrhythmias and some forms of chronic nerve pain.

Yes, Mexiletine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL558. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4178. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.